Subsequently, co-immunoprecipitation assays were undertaken to ascertain whether PRMT6 could physically bind to STAT3, and the results disclosed a substantive interaction between PRMT6 and STAT3 in MCF-7 and MDA-MB-468 cancer cells (Fig. 5a). Here, PRMT6 is linked to cancer.